Diligent Development and Commercialization. On a Research Program-by- Research Program basis, following exercise of the Option with respect to a Research Program, [[Alector:Organization]] (itself or through its Affiliates or Licensees) will devote Commercially Reasonable Efforts to develop and commercialize ​ Product that contains an Optioned Antibody with respect to such Research Program. For clarity, [[Alector:Organization]]’s obligation under this [Section 3.4] (Diligent Development and Commercialization), will be satisfied by devoting Commercially Reasonable Efforts to develop and commercialize ​ irrespective of the number of Optioned Antibodies that exist with respect to such Research Program; provided, however, that development and commercialization of a single Product that contains Optioned Antibodies against more than one Target will count as development and commercialization of a Product against all Research Programs that include such Target (e.g., development of a Multispecific Product with antibodies against multiple Targets will satisfy [[Alector:Organization]]’s diligence obligation with respect to each Research Program that includes such Target). Notwithstanding the foregoing, [[Alector:Organization]] will not be obligated to develop or commercialize ​.

Commercialization Diligence. Ji Xing shall use Diligent Efforts to Commercialize the Product ​. Without limiting the foregoing, Ji Xing shall use Diligent Efforts to ​.

Diligent Development and Commercialization. Following exercise of the Option for a Research Program, iTeos shall devote Commercially Reasonable Efforts to develop, seek Marketing Approval for, and launch and actively commercialize at least ​ Optioned Antibody discovered in each such Research Program. iTeos will provide [[Adimab:Organization]] with an annual written report of Product progress in development and commercialization, iTeos’s activities in that regard. If requested by [[Adimab:Organization]], iTeos shall meet with [[Adimab:Organization]] to discuss such report.

Diligent Efforts. During your employment, you will serve Cabot faithfully and, to the best of your ability,

means, with respect to a pharmaceutical product (including Licensed Product), any and all processes and activities conducted to prepare for and establish and maintain sales for such product, including offering for sale, detailing (including physician targeting), promoting, marketing, advertising, pricing, seeking and securing reimbursement, branding, selling, storing of finished products, transporting and distributing such product. For clarity, Commercialization includes # medical support planning, medical affairs activities, medical education activities and other activities traditionally conducted by medical scientific liaisons, health economics and outcomes researchers and other individuals having similar functions, including gathering and maintaining user feedback and establishing and maintaining one or more call centers in connection therewith, # the conduct of any Post-Approval Activities, including all regulatory matters in support thereof or otherwise necessary to maintain any NDA Approval. “Commercialize” and “Commercialized” has a correlative meaning.

Licensee by itself or through its Sublicensees will use diligent efforts to make one or more Licensed Products and/or Licensed Services (as applicable) commercially available in the Field within the Territory. Without limiting the foregoing, Licensee will:

Licensee by itself, or through its Affiliates and Sublicensees, will use Commercially Reasonable Efforts to research, develop and commercialize at least one Licensed Product in the Field in the Territory. Without limiting the foregoing, Licensee will fulfill the Diligence Milestones specified in Section 2.4 of the Patent License Agreement by the deadlines indicated therein and # use diligent and Commercially Reasonable Efforts to perform and complete the plans described in the annual report submitted pursuant to Section 4.2 (Annual Written Progress Report). Licensor hereby agrees that the efforts of Sublicensees, Affiliates, and any third party contractors shall be deemed the acts of Licensee for purposes of satisfying this Section 2.4, and for the purposes of fees due under [Section 3.1(b)] of the Patent License Agreement.

Licensee by itself or through its Sublicensees will use diligent efforts to make one or more Licensed Products and/or Licensed Services (as applicable) commercially available in the Field within the Territory. Without limiting the foregoing, Licensee will:

Commercialization Diligence. Ji Xing shall use Diligent Efforts to Commercialize the Product ​. Without limiting the foregoing, Ji Xing shall use Diligent Efforts to ​.

Licensee by itself or through its Subsidiaries and Sublicensees will use Commercially Reasonable Efforts to make Licensed Products commercially available in the Field within the Territory. Without limiting the foregoing, Licensee will